Older melanoma patients aged 75 and above retain responsiveness to anti-PD1 therapy: results of a retrospective single-institution cohort study
Sign Up to like & getrecommendations! Published in 2018 at "Cancer Immunology, Immunotherapy"
DOI: 10.1007/s00262-018-2219-8
Abstract: IntroductionThe utility of immunotherapy in elderly melanoma patients is debated. We aimed in this study to evaluate the efficacy and tolerability of immunotherapy among elderly patients.MethodThis is a retrospective single-institution cohort study. Patients aged 75 years… read more here.
Keywords: melanoma; institution cohort; retrospective single; study ... See more keywords